SUNREST Stock Overview
Sunrest Lifescience Limited engages in the marketing of OTC generic pharmaceutical products in India.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Sunrest Lifescience Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹70.25 |
| 52 Week High | ₹84.00 |
| 52 Week Low | ₹57.40 |
| Beta | 0 |
| 1 Month Change | 2.18% |
| 3 Month Change | -6.33% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -11.97% |
Recent News & Updates
Recent updates
Shareholder Returns
| SUNREST | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 0.5% | 0.8% | 0.5% |
| 1Y | n/a | 58.6% | 44.7% |
Return vs Industry: Insufficient data to determine how SUNREST performed against the Indian Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how SUNREST performed against the Indian Market.
Price Volatility
| SUNREST volatility | |
|---|---|
| SUNREST Average Weekly Movement | 8.3% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in IN Market | 9.9% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: SUNREST has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine SUNREST's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | 171 | Nikhilkumar Thakkar | www.sunrestlifescience.com |
Sunrest Lifescience Limited engages in the marketing of OTC generic pharmaceutical products in India. It markets a range of drugs, including anti-bacterial, anti-diarrheal, antifungal, anti-malarial, anti-diabetic, dental cure, anti protozol, anti-histamine, anti-hypertensive, cosmetic, anti-parasitic, multivitamin, multimineral, nutraceutical, and anti-inflammatory drugs. The company was incorporated in 2017 and is based in Ahmedabad, India.
Sunrest Lifescience Limited Fundamentals Summary
| SUNREST fundamental statistics | |
|---|---|
| Market cap | ₹301.46m |
| Earnings (TTM) | ₹20.43m |
| Revenue (TTM) | ₹246.42m |
14.8x
P/E Ratio1.2x
P/S RatioIs SUNREST overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SUNREST income statement (TTM) | |
|---|---|
| Revenue | ₹246.42m |
| Cost of Revenue | ₹148.78m |
| Gross Profit | ₹97.65m |
| Other Expenses | ₹77.21m |
| Earnings | ₹20.43m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.76 |
| Gross Margin | 39.63% |
| Net Profit Margin | 8.29% |
| Debt/Equity Ratio | 68.8% |
How did SUNREST perform over the long term?
See historical performance and comparison